CompletedNot Applicable

Global Kidney Patient Trials Network

Australia5,999 participantsStarted 2020-05-05

Plain-language summary

This is a prospective international multi-centre, observational cohort study of incident and prevalent patients diagnosed with a kidney disease

Age range2 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Documented diagnosis of primary kidney disease
✓. Regular visits (6-12 monthly) with a physician at a participating site that includes the monitoring of protein in urine and kidney function
✓. eGFR \> 25 ml/min/1.73m2
✓. ≥ 2 to ≥ 80 years of age
✓. One of the following laboratory urine parameters within 12 months of screening meeting the values of:
✓. Willing and able to sign informed consent
✓. Willing to be approached about participation in interventional research studies

✕. Life-expectancy of less than 6 months
✕. Currently receiving renal replacement therapy or planned to start in the next 6 months
✕. Planned transplant in the next 6 months
✕. Currently participating in a clinical trial involving investigational medicinal product (exception is participation in studies implemented through the GKPTN)

estimated Glomerular Filtration Rate (eGFR)

Timeframe: Collected Six-Monthly (minimum)

Albuminuria

Timeframe: Collected Six-Monthly (minimum)

NCT IDNCT04389827

SponsorThe George Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-04-30